Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Danger Signal Extracellular ATP Is Involved in the Immunomediated Damage of α-Sarcoglycan-Deficient Muscular Dystrophy.
Gazzerro E, Baratto S, Assereto S, Baldassari S, Panicucci C, Raffaghello L, Scudieri P, De Battista D, Fiorillo C, Volpi S, Chaabane L, Malnati M, Messina G, Bruzzone S, Traggiai E, Grassi F, Minetti C, Bruno C. Gazzerro E, et al. Among authors: malnati m. Am J Pathol. 2019 Feb;189(2):354-369. doi: 10.1016/j.ajpath.2018.10.008. Epub 2018 Nov 16. Am J Pathol. 2019. PMID: 30448410 Free article.
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.
Moroni M, Ghezzi S, Baroli P, Heltai S, De Battista D, Pensieroso S, Cavarelli M, Dispinseri S, Vanni I, Pastori C, Zerbi P, Tosoni A, Vicenzi E, Nebuloni M, Wong K, Zhao H, McHugh S, Poli G, Lopalco L, Scarlatti G, Biassoni R, Mullins JI, Malnati MS, Alfano M. Moroni M, et al. Among authors: malnati ms. J Transl Med. 2014 Dec 5;12:335. doi: 10.1186/s12967-014-0335-6. J Transl Med. 2014. PMID: 25477316 Free PMC article.
Dynamics of adaptive and innate immunity in patients treated during primary human immunodeficiency virus infection: results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial.
Ripa M, Pogliaghi M, Chiappetta S, Galli L, Pensieroso S, Cavarelli M, Scarlatti G, De Biasi S, Cossarizza A, De Battista D, Malnati M, Lazzarin A, Nozza S, Tambussi G. Ripa M, et al. Among authors: malnati m. Clin Microbiol Infect. 2015 Sep;21(9):876.e1-4. doi: 10.1016/j.cmi.2015.05.007. Epub 2015 May 14. Clin Microbiol Infect. 2015. PMID: 25980351 Free article. Clinical Trial.
Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study.
Nozza S, Galli L, Antinori A, Chiappetta S, Mazzotta F, Zaccarelli M, Ottou S, De Battista D, Pogliaghi M, Di Pietro M, Malnati M, Ripa M, Bonora S, Lazzarin A; VEMAN Study Group. Nozza S, et al. Among authors: malnati m. Clin Microbiol Infect. 2015 May;21(5):510.e1-9. doi: 10.1016/j.cmi.2014.12.006. Epub 2014 Dec 11. Clin Microbiol Infect. 2015. PMID: 25656621 Free article. Clinical Trial.
Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.
Parolini F, Biswas P, Serena M, Sironi F, Muraro V, Guizzardi E, Cazzoletti L, Scupoli MT, Gibellini D, Ugolotti E, Biassoni R, Beretta A, Malnati M, Romanelli MG, Zipeto D. Parolini F, et al. Among authors: malnati m. J Virol. 2017 Dec 14;92(1):e01711-17. doi: 10.1128/JVI.01711-17. Print 2018 Jan 1. J Virol. 2017. PMID: 29070683 Free PMC article.
100 results